642
D. A. Sibgatulin et al.
3
3JHH = 8.1 Hz, CH2), 3.03 (1H, dd, JHH = 16.8 Hz,
was maintained at rt for 6–8 h. The ether was decanted
3JHH = 3.3 Hz, CH2), 3.54 (2H, s, CH3), 4.17 (2H, q,
3JHH = 7.2 Hz, OCH2), 5.48 (1H, dd, JHH = 8.1 Hz,
3JHH = 3.3 Hz, CH), 7.48–7.66 (3H, m, CH), 7.93 (2H, d,
3JHH = 7.2 Hz, CH) ppm; 13C NMR (125 MHz, CDCl3):
d = 14.1, 47.7, 50.1, 61.6, 69.8, 128.7, 129.0, 133.2, 134.2,
166.8, 199.9, 200.3 ppm.
from the precipitate, which was crystallized from n-hexane.
3
Ethyl 5-hydroxy-3-pyrrolidin-1-yl-6-oxo-6-phenylhex-2-
enoate (6a, C18H23NO4)
1
Yellow solid; mp = 85 °C; H NMR (300 MHz, CDCl3):
d = 1.28 (3H, t, 3JHH = 7.2, CH3), 1.88 (4H, br s, CH2), 2.97
(1H, dd, JHH = 11.7 Hz, CH2), 3.26 (4H, m, NCH2), 3.52
2
(1H, m, CH2),4.14(2H, q,3JHH = 7.2 Hz, OCH2),4.6(2H, br
s, CH and OH), 5.39(1H, dd, 3JHH = 11.7 Hz, CH), 7.52(3H,
5-Hydroxy-1,6-diphenyl-3-(pyrrolidin-1-yl)-hex-2-en-1,6-
dione (9a, C22H23NO3)
Colourless solid; mp = 132 °C; 1H NMR (300 MHz,
DMSO-d6): d = 1.88 (4H, br s, CH2), 3.09 (1H, m, CH2),
3.48 and 3.54 (4H, m, NCH2), 3.79 (1H, m, CH2), 5.39 (1H,
m, CH), 5.67 (1H, s, CH), 6.05 (1H, d, 3JHH = 6.9 Hz, OH),
3
m, CH), 8.26 (2H, d, JHH = 7.1 Hz, CH) ppm; 13C NMR
(125 MHz,C6D6):d = 14.8,24.7, 36.1, 48.1,58.5,73.4, 84.9,
128.6, 129.9, 133.6, 134.3, 159.0, 169.7, 201.7 ppm.
Ethyl 5-hydroxy-3-morpholin-4-yl-6-oxo-6-phenylhex-2-
enoate (6b, C18H23NO5)
3
7.44–7.65 (6H, m, CH), 7.86 (2H, d, JHH = 7.1 Hz, CH),
8.14 (2H, d, 3JHH = 7.1 Hz, CH) ppm; 13C NMR (125 MHz,
DMSO-d6): d = 26.7, 51.1, 69.4, 87.1, 126.4, 127.5, 128.4,
129.1, 138.6, 163.4, 197.5, 199.6 ppm; MS (EI 70 eV): m/z
(%) = 349 (11) [M?], 331 (17) [M? - H2O], 244 (16)
[M? - PhCO], 226 (100) [M? - PhCO - H2O], 105 (92)
[PhCO?], 77 (61) [Ph?], 70 (50).
Yellow solid; mp = 95–97 °C; 1H NMR (300 MHz,
3
CDCl3): d = 1.27 (3H, t, JHH = 7.2 Hz, CH3), 2.95
2
3
(1H, dd, JHH = 14.1 Hz, JHH = 9.9 Hz, CH2), 3.24
(4H, m, NCH2), 3.66 (5H, m), 4.14 (2H, q, 3JHH = 7.2 Hz,
3
OCH2), 4.89 (1H, s, CH), 5.35 (1H, dd, JHH = 9.9 Hz,
3JHH = 4.5 Hz, CH), 7.55 (3H, m, CH), 8.21 (2H, d,
3JHH = 7.2 Hz, CH) ppm; 13C NMR (125 MHz, C6D6):
d = 14.6, 37.5, 49.6, 58.7, 66.3, 74.1, 82.1, 128.5, 130.1,
132.5, 133.7, 160.1, 168.6, 200.8 ppm; MS (EI 70 eV): m/z
(%) = 333 (6) [M?], 315 (38), 242 (100), 172 (11), 128
(15), 77 (10).
5-Hydroxy-1,6-diphenyl-3-(4-morpholinyl)hex-2-en-1,6-
dione (9b, C22H23NO4)
1
Colourless solid; mp = 121–123 °C; H NMR (300 MHz,
DMSO-d6): d = 2.81 (1H, m, CH2), 3.26 (5H, m, NCH2
and CH2), 3.71 (4H, m, OCH2), 5.22 (1H, m, CH), 5.53
(1H, s, CH), 7.31–7.52 (6H, m, CH), 7.91 (2H, d,
3JHH = 7.2 Hz, CH), 8.15 (2H, d, JHH = 7.2 Hz, CH)
ppm; 13C NMR (75 MHz, DMSO-d6): d = 37.5, 48.6,
66.8, 73.4, 89.5, 127.3, 128.0, 128.5, 130.2, 130.6, 167.4,
197.3, 200.1 ppm.
Ethyl 4-oxo-5-phenyl-2-(pyrrolidin-1-yl)cyclopent-1-
enoate (7, C18H21NO3)
3
The general procedure was applied. The resulting reaction
mixture was maintained at rt for 48 h (or heated under reflux
for 5 h). The ether was decanted from the precipitate, which
was crystallized from n-pentane. Colourless solid;
1
General procedure for synthesis of cyclic compounds 10
mp = 112 °C; H NMR (300 MHz, DMSO-d6): d = 1.33
(3H, t, JHH = 7.5 Hz, CH3), 2.03 (4H, t, JHH = 5.4 Hz,
3
3
To a solution of 2.5 mmol acyclic compound in 10 cm3
benzene was added 0.1 cm3 concentrated HCl and the
mixture was maintained at rt for 12 h. The benzene was
decanted from the precipitated oil, and the oil was dis-
solved in EtOH and maintained at 0 °C for 2 h. The
precipitate formed was collected by filtration.
3
CH2), 3.45 (4H, t, JHH = 5.4 Hz, NCH2), 3.63 and 4.04
2
(1H, 2H, AB-syst., JHH = 3.4 Hz), 4.31 (2 h, q,
3JHH = 7.5 Hz, CH2), 5.05 (1H, s, CH), 7.3 (2H, d,
3
3JHH = 8.9 Hz, CH), 7.38 (1H, d, JHH = 8.9 Hz, CH),
7.45 (2H, t, 3JHH = 8.9 Hz, CH) ppm; 13C NMR (125 MHz,
C6D6): d = 14.2, 25.2, 46.3, 52.3, 54.7, 59.4, 92.3, 126.5,
129.3, 131.5, 167.4, 209.4 ppm; MS (EI 70 eV): m/z
(%) = 299 (37) [M?], 226 (100), 128 (10), 70 (21).
3-Benzoyl-2-phenyl-4-(pyrrolidin-1-yl)cyclopent-3-enone
(10a, C22H21NO2)
Colourless solid; mp = 191 °C; 1H NMR (300 MHz,
Ethyl 5-hydroxy-4,6-dioxo-6-phenylhexanoate
(8, C14H16O5)
3
DMSO-d6): d = 1.82 (4H, t, JHH = 6.6 Hz, CH2), 3.45
3
2
(4H, t, JHH = 6.6 Hz), 3.69 (1H, d, JHH = 3.4 Hz), 4.02
(1H, d, 2JHH = 3.4 Hz), 5.2 (1H, s, CH), 7.18 (2H, m, CH),
7.31–7.45 (5H, m, CH), 7.7–7.81 (3H, m, CH) ppm; 13C
NMR (75 MHz, DMSO-d6): d = 25.8, 48.6, 53.1, 57.3,
92.7, 126.7, 127.3, 127.9, 129.8, 137.3, 154.1, 191.4,
208.4 ppm; MS (EI 70 eV): m/z (%) = 331 (46) [M?], 226
(100), 105 (75), 77 (43).
Functionalized enamine 6b (1 g, 3 mmol) was dissolved in
15 cm3 dichloromethane and 15 cm3 5% aq. HCl were
added. The resulting two-phase system was stirred at rt for
48 h. The organic layer was dried over sodium sulfate,
filtered, and evaporated. Light yellow solid; mp = 73 °C;
1H NMR (300 MHz, CDCl3): d = 1.26 (3H, t,
3
3JHH = 7.2 Hz, CH3), 2.86 (1H, dd, JHH = 16.8 Hz,
123